SHOULD RARITY MATTER? RESULTS OF A SOCIAL WILLINGNESS-TO-PAY STUDY USING THE DISCRETE CHOICE EXPERIMENT (DCE) METHOD IN SWITZERLAND

Author(s)

Schlander M1, Telser H2, Fischer B2, Rechenberg Tv2, Schaefer R1
1German Cancer Research Center (DKFZ), Heidelberg, Germany, 2Polynomics AG, Olten, Switzerland

OBJECTIVES: In most stated preference studies in health economics the valuation of health states has reflected individual (“selfish”) preferences only. Social willingness-to-pay (WTP), i.e., WTP an extra in public tax or mandatory health insurance premiums in exchange for access to a health care intervention, should allow to also capture option value and caring externalities. We designed a Discrete Choice Experiment (DCE) to explore social preferences of citizens in Switzerland with regard to coverage decisions by mandatory health insurance, with particular attention to the potential role of rarity.

METHODS: Based on a literature review, a Swiss multi-stakeholder consensus (“SwissHTA”), and an international expert consensus, we identified severity, health gain, age, and prevalence as relevant attributes of health care interventions, using additional health insurance premiums as cost attribute. Following pretests, the survey enrolled 1,501 respondents, who had participated in an initial preference formation phase. We assessed the relative importance of the attributes and – by randomization into subgroups – the impact on choices by the level of information on “rarity” and cost per patient (framing effects). The study further included a utility comparator.

RESULTS: We find empirical support for the importance of all attributes tested, with health gains (changes in life expectancy and quality of life) and incremental cost (from a citizens’ perspective) being more relevant than prevalence and the age effect observed in the experiment. Despite decreasing social WTP with decreasing prevalence, our data point to a profound increase of implied WTP per case with decreasing prevalence.

CONCLUSIONS: Results suggest that all attributes tested contribute to the social valuation of health interventions, in contrast to the assumptions underlying the conventional logic of cost effectiveness – indicating potentially far-reaching implications for the use of economic evaluation in the context of HTAs. We will discuss limitations of the study and future research needs.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Value in Health, Vol. 21, S3 (October 2018)

Code

PSY224

Topic

Health Policy & Regulatory

Topic Subcategory

Public Spending & National Health Expenditures

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×